PASCUAL TORRES CABESTANY-rekin lankidetzan egindako argitalpenak (20)

2024

  1. Can Glatiramer Acetate Prevent Cognitive Impairment by Modulating Oxidative Stress in Patients with Multiple Sclerosis?

    Pharmaceuticals, Vol. 17, Núm. 4

  2. Glycogen accumulation modulates life span in a mouse model of amyotrophic lateral sclerosis

    Journal of Neurochemistry, Vol. 168, Núm. 5, pp. 744-759

2023

  1. A prospective study of cellular immune response to booster COVID-19 vaccination in multiple sclerosis patients treated with a broad spectrum of disease-modifying therapies

    Journal of Neurology, Vol. 270, Núm. 5, pp. 2380-2391

  2. Cyanovirin-N binds to select SARS-CoV-2 spike oligosaccharides outside of the receptor binding domain and blocks infection by SARS-CoV-2

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 120, Núm. 10

  3. Seroprevalence of SARS-CoV-2 in Patients with Multiple Sclerosis under Disease-Modifying Therapies: A Multi-Centre Study

    Journal of Clinical Medicine, Vol. 12, Núm. 23

2022

  1. A motor neuron disease mouse model reveals a non-canonical profile of senescence biomarkers

    Disease models & mechanisms, Vol. 15, Núm. 8

  2. Seroprevalence of SARS‐CoV‐2 in a Cohort of Patients with Multiple Sclerosis under Disease‐Modifying Therapies

    Journal of Clinical Medicine, Vol. 11, Núm. 9

2021

  1. Acute ischemic stroke triggers a cellular senescence-associated secretory phenotype

    Scientific Reports, Vol. 11, Núm. 1

  2. Age-related changes in lipidome of rat frontal cortex and cerebellum are partially reversed by methionine restriction applied in old age

    International Journal of Molecular Sciences, Vol. 22, Núm. 22

  3. Cell stress induces mislocalization of transcription factors with mitochondrial enrichment

    International Journal of Molecular Sciences, Vol. 22, Núm. 16

  4. Lipidomic traits of plasma and cerebrospinal fluid in amyotrophic lateral sclerosis correlate with disease progression

    Brain Communications, Vol. 3, Núm. 3

  5. New insights into human prefrontal cortex aging with a lipidomics approach

    Expert Review of Proteomics, Vol. 18, Núm. 5, pp. 333-344

  6. Nuclear lipidome is altered in amyotrophic lateral sclerosis: A pilot study

    Journal of Neurochemistry, Vol. 158, Núm. 2, pp. 482-499

  7. The causal role of lipoxidative damage in mitochondrial bioenergetic dysfunction linked to alzheimer’s disease pathology

    Life, Vol. 11, Núm. 5

2020

  1. Gender-Specific Beneficial Effects of Docosahexaenoic Acid Dietary Supplementation in G93A-SOD1 Amyotrophic Lateral Sclerosis Mice

    Neurotherapeutics, Vol. 17, Núm. 1, pp. 269-281

  2. Selected cryptic exons accumulate in hippocampal cell nuclei in Alzheimer's disease with and without associated TDP-43 proteinopathy

    Brain

2019

  1. Altered dynein axonemal assembly factor 1 expression in C-boutons in bulbar and spinal cord motor-neurons in sporadic amyotrophic lateral sclerosis

    Journal of Neuropathology and Experimental Neurology, Vol. 78, Núm. 5, pp. 416-425

2018

  1. Cryptic exon splicing function of TARDBP interacts with autophagy in nervous tissue

    Autophagy, Vol. 14, Núm. 8, pp. 1398-1403

2016

  1. Early and gender-specific differences in spinal cord mitochondrial function and oxidative stress markers in a mouse model of ALS

    Acta neuropathologica communications, Vol. 4, pp. 3

  2. Interplay between TDP-43 and docosahexaenoic acid-related processes in amyotrophic lateral sclerosis

    Neurobiology of Disease, Vol. 88, pp. 148-160